<DOC>
	<DOC>NCT01250197</DOC>
	<brief_summary>This is a double-masked, single-center, crossover study in which normal volunteers will be randomized to receive one of two formulations of 0.5% AR-12286 Ophthalmic Solution for 8 days. Subjects will undergo a minimum 7-day washout, and then receive the alternate treatment for 8 days.</brief_summary>
	<brief_title>Formulation Comparison in Normal Volunteers</brief_title>
	<detailed_description>Not desired.</detailed_description>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Normal volunteers Active ophthalmic or systemic disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>Normal Volunteers</keyword>
</DOC>